Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2420 (LINC02420)

Target
LINC02420
Molecular classification
Long non-coding RNA (lncRNA), Long intergenic non-coding RNA (lincRNA)
01

Overview

Long intergenic non-protein coding RNA 2420 (LINC02420) is a long intergenic non-coding RNA (lincRNA), which are transcripts longer than 200 nucleotides that do not overlap protein-coding genes.[1][3][5] LincRNAs are a subclass of long non-coding RNAs (lncRNAs) and are defined by their genomic position in intergenic regions.[5] They are transcribed by RNA polymerase II, often capped and spliced, and display tissue specificity in their expression.[1] LincRNAs, including LINC02420, generally function in fine-tuning gene expression, chromatin remodeling, acting as scaffolds for protein complexes, and stabilizing RNA transcripts.[1][5] While lincRNAs as a class are increasingly recognized as important regulators in development, cellular differentiation, and disease (notably cancer), LINC02420 itself does not have specific functional or disease associations established in the major literature or molecular classification systems at this time.[3][5] If more specific information (e.g., literature demonstrating a role in a particular pathway or disease) becomes available for LINC02420, it should be added to this entry. Currently, it represents a specific genetic locus within the general lincRNA family, not a canonical therapeutic target or biomarker.

Other names
LINC02420Long intergenic non-protein coding RNA 2420
02

Mechanism of action

Not applicable; no drug interactions known.

03

Biological functions

Transcriptional regulationChromatin remodelingScaffolding/modulation of protein complexesRNA stabilizationGene expression fine-tuningPotential enhancer-associated activity
04

Disease associations

Cancer

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2420 (LINC02420).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2420 (LINC02420).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call